Humoral and cellular responses after a third dose of BNT162b2 vaccine in patients treated for lymphoid malignancies
Daniel Re, Barbara Seitz-Polski, Michel Carles, Vesna Brglez, Daisy Graça, Sylvia Benzaken, Stéphane Liguori, Khaled Zahreddine, Margaux Delforge, Benjamin Verrière, Emmanuel Chamorey, Barrière Jérôme
doi: https://doi.org/10.1101/2021.07.18.21260669
Daniel Re
1Department of Hematology and Medical Oncology, Centre Hospitalier Antibes-Juan les Pins, 107 Route de Nice, 06600 Antibes, FRANCE
MD, PhDBarbara Seitz-Polski
2Laboratoire d’Immunologie, Centre Hospitalier Universitaire (CHU) de Nice, Université Côte d’Azur, Nice, France
MD, PhDMichel Carles
3Department of infectious disease, Centre Hospitalo-Universitaire de Nice, ARCHET 1 06000 NICE, France
MD., Ph D.Vesna Brglez
2Laboratoire d’Immunologie, Centre Hospitalier Universitaire (CHU) de Nice, Université Côte d’Azur, Nice, France
PhDDaisy Graça
4Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d’Azur, Nice, France
Sylvia Benzaken
4Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d’Azur, Nice, France
MDStéphane Liguori
5Department of Medical Biology, Centre Hospitalier, Antibes, France
MDKhaled Zahreddine
5Department of Medical Biology, Centre Hospitalier, Antibes, France
MDMargaux Delforge
6Department of Pharmacy, Centre Hospitalier, Antibes, France
PharmDBenjamin Verrière
6Department of Pharmacy, Centre Hospitalier, Antibes, France
PharmDEmmanuel Chamorey
7Department of Biostatistics and Epidemiology., Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France
PharmD., PhDBarrière Jérôme
8Department of Medical Oncology, Polyclinique Saint Jean, 92 avenue Dr Donat, 06800 Cagnes-sur-Mer, France
MD.Article usage
Posted July 22, 2021.
Humoral and cellular responses after a third dose of BNT162b2 vaccine in patients treated for lymphoid malignancies
Daniel Re, Barbara Seitz-Polski, Michel Carles, Vesna Brglez, Daisy Graça, Sylvia Benzaken, Stéphane Liguori, Khaled Zahreddine, Margaux Delforge, Benjamin Verrière, Emmanuel Chamorey, Barrière Jérôme
medRxiv 2021.07.18.21260669; doi: https://doi.org/10.1101/2021.07.18.21260669
Humoral and cellular responses after a third dose of BNT162b2 vaccine in patients treated for lymphoid malignancies
Daniel Re, Barbara Seitz-Polski, Michel Carles, Vesna Brglez, Daisy Graça, Sylvia Benzaken, Stéphane Liguori, Khaled Zahreddine, Margaux Delforge, Benjamin Verrière, Emmanuel Chamorey, Barrière Jérôme
medRxiv 2021.07.18.21260669; doi: https://doi.org/10.1101/2021.07.18.21260669
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2915)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12709)
- Forensic Medicine (12)
- Gastroenterology (826)
- Genetic and Genomic Medicine (4566)
- Geriatric Medicine (414)
- Health Economics (726)
- Health Informatics (2912)
- Health Policy (1068)
- Hematology (385)
- HIV/AIDS (921)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4331)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (497)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6914)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (383)
- Surgery (484)
- Toxicology (60)
- Transplantation (210)
- Urology (178)